GMPS: A Protein with Potential as A Drug Target Or Biomarker (G8833)

Target Name: GMPS

NCBI ID: G8833

GMPS

GMPS: A Protein with Potential as A Drug Target Or Biomarker

GMPS, or Glycophosphamide-Inducible Atypical Calcification, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been linked to a number of diseases, including cancer. In recent years, researchers have been interested in studying GMPS as a potential drug target or biomarker.

One of the key reasons for the interest in GMPS is its ability to induce apoptosis, or cell death, in certain cells. This process is important for eliminating cells that are no longer needed, and is thought to be a key mechanism in the regulation of tissue homeostasis. In addition, GMPS has been shown to play a role in the development of certain diseases, including cancer.

As a result, GMPS has been identified as a potential drug target for a number of different diseases. For example, studies have shown that inhibiting GMPS can lead to a reduction in the growth and spread of cancer cells. In addition, GMPS has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

Another promising aspect of GMPS is its ability to serve as a biomarker. By measuring the levels of GMPS in different tissues and fluids, researchers can gain insights into the health of the body and the presence of certain diseases. This has the potential to be a useful diagnostic tool, particularly in cases where disease cannot be detected through other means.

Despite the potential benefits of GMPS as a drug target or biomarker, much more research is needed before it can be fully understood and harnessed for these purposes. One of the main challenges in studying GMPS is its complex structure and the difficulty of modifying it in order to study its effects. In addition, the lack of clear understanding of its underlying mechanisms can make it difficult to predict its potential responses to different treatments.

Despite these challenges, researchers are making progress in understanding the role of GMPS in different diseases. By continuing to study its effects and its potential as a drug target or biomarker, researchers hope to be able to develop new treatments for a variety of diseases.

Protein Name: Guanine Monophosphate Synthase

Functions: Catalyzes the conversion of xanthine monophosphate (XMP) to GMP in the presence of glutamine and ATP through an adenyl-XMP intermediate

The "GMPS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GMPS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets